Fineman MS, Bryant CLN, Colbert K, Jozefiak TH, et al. First-in-human study of a pharmacological duodenal exclusion therapy shows reduced postprandial glucose and insulin and increased bile acid and gut hormone concentrations. Diabetes Obes Metab 2023;25:2447-2456.
PMID: 37380614